Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Laboratory Corp of America Holdings (LH) Com Stk USD0.1

Sell:$206.36 Buy:$206.49 Change: $4.53 (2.24%)
Market closed |  Prices as at close on 27 October 2020 | Switch to live prices |
Sell:$206.36
Buy:$206.49
Change: $4.53 (2.24%)
Market closed |  Prices as at close on 27 October 2020 | Switch to live prices |
Sell:$206.36
Buy:$206.49
Change: $4.53 (2.24%)
Market closed |  Prices as at close on 27 October 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.

Contact details

Address:
358 S MAIN ST
BURLINGTON
27215-5837
United States
Telephone:
+1 (336) 2291127
Website:
https://www.labcorp.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
LH
ISIN:
US50540R4092
Market cap:
$20.11 billion
Shares in issue:
97.40 million
Sector:
Health Care Services
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Adam Schechter
    President, Chief Executive Officer, Director
  • Glenn Eisenberg
    Chief Financial Officer, Executive Vice President
  • Judith Seltz
    Chief Human Resource Officer, Executive Vice President
  • Lance Berberian
    Executive Vice President, Chief Technology Officer, Chief Information Officer
  • Amy Summy
    Executive Vice President, Chief Marketing Officer
  • Sandra Van Der Vaart
    Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary
  • Brian Caveney
    Executive Vice President, President, Diagnostics and Chief Medical Officer
  • Paul Kirchgraber
    Executive Vice President and Chief Executive Officer - Covance Drug Development
  • Mark Schroeder
    Executive Vice President, President of Diagnostics Laboratory Operations and Global Supply Chain
  • Peter Wilkinson
    Senior Vice President, Chief Accounting Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.